Profilo
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Precedenti posizioni note di Christopher Seiter
| Società | Posizione | Fine |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Direttore Finanziario/CFO | 02/04/2021 |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Direttore Finanziario/CFO | - |
Formazione di Christopher Seiter
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Finance |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















